Acrotech Biopharma, LLC et al v. Fresenius Kabi USA, LLC et al
Spectrum Pharmaceuticals, Inc., TopoTarget UK Ltd. and Acrotech Biopharma, LLC |
Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, Inc. and Fresenius Kabi USA, LLC |
1:2018cv01533 |
October 3, 2018 |
US District Court for the District of Delaware |
Colm F Connolly |
Sherry R Fallon |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. § 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on December 2, 2020. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 126 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,888,027 ;US 8,835,501. (Attachments: #1 Dismissal Order)(fms) |
|
Filing 124 REDACTED VERSION of #123 Stipulation of Dismissal by Acrotech Biopharma, LLC, TopoTarget UK Ltd.. (Silver, Daniel) |
Filing 123 [SEALED] STIPULATION of Dismissal by Acrotech Biopharma, LLC, TopoTarget UK Ltd.. (Attachments: #1 Certificate of Service)(Silver, Daniel) |
Minute Entry for proceedings held before Judge Colm F. Connolly - Oral Argument held on 11/5/2020. (Court Reporter V. Gunning.) (nmf) |
|
Filing 122 MOTION for Pro Hac Vice Appearance of Attorney Jason G. Harp - filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC. (Farnan, Brian) |
|
|
Filing 121 MOTION for Pro Hac Vice Appearance of Attorney Daniel J. Minion - filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd.. (Attachments: #1 Certification for Daniel J. Minion)(Silver, Daniel) |
Filing 120 STIPULATION TO EXTEND TIME to EXTEND the deadline for Daubert Motions to 12/1/2020 - filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC. (Farnan, Brian) |
|
|
Filing 119 NOTICE OF SERVICE of Reply Expert Report of Lucas J. Tucker, Ph.D. Concerning Infringement filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd..(Silver, Daniel) |
|
Filing 118 STIPULATION TO EXTEND TIME the Deadline for Expert Discovery to November 24, 2020 - filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd.. (Silver, Daniel) |
Filing 117 REDACTED VERSION of #116 Response to Objections by Acrotech Biopharma, LLC, TopoTarget UK Ltd.. (Silver, Daniel) |
Filing 116 [SEALED] RESPONSE TO OBJECTIONS by Acrotech Biopharma, LLC, TopoTarget UK Ltd. re #111 Objections, . (Attachments: #1 Exhibit A-B, #2 Word Certification, #3 Certificate of Service)(Joyce, Alexandra) |
Filing 115 NOTICE OF SERVICE of (i) Reply Expert Report of Jeffrey M. Besterman, Ph.D Regarding Invalidity of U.S. Patent No. 6,888,027 and (ii) Reply Expert Report of Dr. Alexander M. Klibanov filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
Filing 114 REDACTED VERSION of #111 Objections, by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC. (Attachments: #1 Exhibits A-B, #2 Certification)(Farnan, Brian) |
CORRECTING ENTRY: Exhibit B to the Sealed Objections at D.I. #111 has been replaced with a corrected version per request of filer. (nmf) |
Filing 113 REDACTED VERSION of #110 Letter by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC. (Farnan, Michael) |
Filing 112 REDACTED VERSION of #109 Letter, by Acrotech Biopharma, LLC, TopoTarget UK Ltd.. (Joyce, Alexandra) |
Filing 111 [SEALED] OBJECTIONS by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC to Oral Order. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Certification Pursuant to Standing Order for Objections Filed Under Fed. R. Civ. P. 72)(Farnan, Brian) Modified on 9/18/2020 (lih). (Attachment 2 replaced on 9/24/2020) (nmf, ). |
|
Minute Entry for proceedings held before Judge Sherry R. Fallon - Discovery Dispute Telephone Conference held on 9/16/2020. (Court Reporter S. Ingram (Hawkins Reporting).) (lih) |
Filing 110 [SEALED] Letter to The Honorable Sherry R. Fallon from Michael J. Farnan - re #109 Letter. (Farnan, Michael) Modified on 9/15/2020 (lih). |
Filing 109 [SEALED] Letter to The Honorable Magistrate Sherry R. Fallon from Daniel M. Silver regarding discovery dispute. (Attachments: #1 Exhibit A-E, #2 Text of Proposed Order, #3 Certificate of Service)(Silver, Daniel) Modified on 9/14/2020 (lih). |
|
Filing 108 Letter to the Honorable Sherry R. Fallon from Daniel M. Silver, Esq. regarding Request for Continued Discovery Conference at the Courts Earliest Convenience. (Silver, Daniel) Modified on 9/10/2020 (lih). |
Filing 107 REDACTED VERSION of #105 Letter by Acrotech Biopharma, LLC, TopoTarget UK Ltd.. (Silver, Daniel) |
Filing 106 REDACTED VERSION of #104 Letter by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC. (Attachments: #1 Exhibits 1-3)(Farnan, Brian) |
|
Minute Entry for proceedings held before Judge Sherry R. Fallon - Discovery Dispute Telephone Conference held on 9/3/2020. (Court Reporter V. Gunning.) (lih) |
Filing 105 [SEALED] Letter to The Honorable Magistrate Sherry R. Fallon from Daniel M. Silver regarding Responsive Letter - re Oral Order,. (Attachments: #1 Exhibit A-D, #2 Certificate of Service)(Silver, Daniel) |
Filing 104 [SEALED] Letter to The Honorable Sherry R. Fallon from Brian E. Farnan regarding Discovery Dispute. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Farnan, Brian) |
Filing 103 NOTICE OF SERVICE of (1) Rebuttal Expert Report of Robert O. Williams III, Ph.D. Regarding Validity of U.S. Patent No. 8,835,501; (2) Rebuttal Expert Report of Robert R. Ruffolo Jr., Ph.D. filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd..(Silver, Daniel) |
Filing 102 NOTICE OF SERVICE of (i) Responsive Noninfringement Report of Michael J. Thirman, MD and (ii) Rebuttal Expert Report of Dr. Alexander M. Klibanov filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
Reset Hearings: A Telephone Conference is set for 9/3/2020 at 11:00 AM before Judge Sherry R. Fallon per oral order entered on 8/18/2020. (lih) |
|
Filing 101 MOTION for Teleconference to Resolve Discovery Dispute - filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC. Motions referred to Sherry R. Fallon.(Farnan, Michael) |
|
Filing 100 NOTICE OF SERVICE of (1) Opening Expert Report of Robert O. Williams III, Ph.D. Concerning Infringement; (2) Opening Expert Report of Lucas J. Tucker, Ph.D. Concerning Infringement; and (3) Opening Expert Report of Andrei Shustov, M.D. Concerning Infringement filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd..(Silver, Daniel) |
Filing 99 NOTICE OF SERVICE of i) Expert Report of Dr. Alexander M. Klibanov and (ii) Opening Expert Report of Jeffrey M. Besterman, Ph. D Regarding Invalidity of U.S. Patent No. 6,888,027 filed by Fresenius Kabi USA, LLC.(Farnan, Brian) |
Filing 98 NOTICE OF SERVICE of Defendants Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Limited's Supplemental Objections and Responses to Interrogatory No. 4 filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
|
|
Filing 95 NOTICE OF SERVICE of Fresenius Kabi's Invalidity Contentions filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
Filing 94 NOTICE OF SERVICE of Plaintiffs' Final Infringement Contentions filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd..(Silver, Daniel) |
|
Filing 93 Joint STIPULATION and [Proposed] Order Regarding Certain Facts on Proposed Labeling and Indications by Acrotech Biopharma, LLC, TopoTarget UK Ltd.. (Joyce, Alexandra) |
Filing 92 NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Third Set of Interrogatories (No. 19) filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd..(Silver, Daniel) |
|
Filing 90 STIPULATION Amending Scheduling Order by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC. (Farnan, Michael) |
Filing 89 NOTICE OF SERVICE of Plaintiffs Second Supplemental Response to Defendants Interrogatory No. 4 filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd..(Silver, Daniel) |
Filing 88 NOTICE OF SERVICE of Declaration of Beverly Lubit filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd..(Silver, Daniel) |
Filing 87 REDACTED VERSION of #85 Letter by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC. (Attachments: #1 Exhibits H-I)(Farnan, Michael) |
Filing 86 REDACTED VERSION of #83 Letter, by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC. (Attachments: #1 Exhibits A-G)(Farnan, Michael) |
|
Minute Entry for proceedings held before Judge Sherry R. Fallon - Discovery Dispute Telephone Conference held on 5/21/2020. (Court Reporter V. Gunning.) (lih) |
Filing 85 [SEALED] Letter to The Honorable Sherry R. Fallon from Michael J. Farnan regarding Response to Plaintiffs' May 18, 2020 Letter - re #82 Letter. (Attachments: #1 Exhibit H, #2 Exhibit I)(Farnan, Michael) |
Filing 84 Letter to The Honorable Sherry R. Fallon from Daniel M. Silver, Esq. regarding Plaintiffs' Responsive Discovery Letter. (Attachments: #1 Exhibit A-E)(Silver, Daniel) |
Filing 83 [SEALED] Letter to The Honorable Sherry R. Fallon from Michael J. Farnan regarding Discovery Dispute. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G)(Farnan, Michael) |
Filing 82 Letter to The Honorable Sherry R. Fallon from Daniel M. Silver, Esq. regarding discovery dispute. (Attachments: #1 Exhibit 1-5, #2 Text of Proposed Order)(Silver, Daniel) Modified on 5/18/2020 (lih). |
|
Filing 80 NOTICE to Take Deposition of 30(B)(6) to Defendants Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Ltd. on May 29, 2020 filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd..(Silver, Daniel) |
Filing 79 MOTION for Teleconference to Resolve Discovery Disputes - filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC. Motions referred to Sherry R. Fallon.(Farnan, Michael) |
|
Filing 78 NOTICE OF SERVICE of Fresenius Kabi's Third Set of Interrogatories to Plaintiffs (No. 19) filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
Pro Hac Vice Attorney Ahmed M.T. Riaz for Fresenius Kabi Oncology Ltd. and Fresenius Kabi USA, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
Filing 77 NOTICE OF SERVICE of Fresenius' Responses and Objections to Plaintiffs' First Set of Admission (Nos. 1-11) to Defendants Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Ltd. filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
Filing 76 STIPULATION TO EXTEND TIME to EXTEND the deadlines for: (i) End of Fact Discovery, Final Infringement and Invalidity Contentions; (ii) Opening Expert Report; (iii) Rebuttal Reports; (iv) Reply Report; and (v) Expert Discovery Deadline to (i) 6/1/2020; (ii) 6/29/2020; (iii) 8/10/2020; (iv) 9/14/2020; and (v) 11/9/2020 - filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC. (Farnan, Michael) |
|
|
Pro Hac Vice Attorney Joshua I. Rothman for Acrotech Biopharma, LLC and TopoTarget UK Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
|
Filing 74 MOTION for Pro Hac Vice Appearance of Attorney Joshua I. Rothman - filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd.. (Silver, Daniel) |
|
Filing 72 NOTICE OF SERVICE of Plaintiffs Responses and Objections to Defendants Second Set of Interrogatories (Nos. 9-18) filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd..(Silver, Daniel) |
Filing 71 NOTICE OF SERVICE of (1) Plaintiffs Responses and Objections to Defendants Notice of Deposition of Acrotech Biopharma, LLC Pursuant to Federal R. Civ. P. 30(b)(6); (2) Plaintiffs Responses and Objections to Defendants Notice of Deposition of Topotarget UK Ltd. Pursuant to Federal R. Civ. P. 30(b)(6); (3) Plaintiffs First Set of Requests for Admission (Nos. 1-11) to Defendants Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Ltd. filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd..(Silver, Daniel) |
Filing 70 NOTICE OF SERVICE of Plaintiffs First Supplemental Responses to Defendants Interrogatory Nos. 4, 6, 7, and 8 filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd..(Silver, Daniel) |
Filing 69 NOTICE OF SERVICE of Fresenius Kabi's Second Set of Interrogatories to Plaintiffs (Nos. 9-18) filed by Fresenius Kabi USA, LLC.(Farnan, Michael) |
|
Filing 67 Joint PROPOSED ORDER re: Claim Construction by Acrotech Biopharma, LLC, TopoTarget UK Ltd.. (Joyce, Alexandra) |
Filing 66 REDACTED VERSION of #56 Letter, by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC. (Attachments: #1 Exhibit Exhibits A-F, #2 Text of Proposed Order, #3 Certification)(Farnan, Brian) |
Filing 65 NOTICE to Take Deposition of Einars Loza on 3/27/2020 filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
Filing 64 NOTICE to Take Deposition of Nicholas J. Hughes on 4/3/2020 filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
Filing 63 NOTICE to Take Deposition of Paul W. Finn on 3/24/2020 filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
Filing 62 NOTICE to Take Deposition of Richard J. Bastin on 3/31/2020 filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
Filing 61 NOTICE to Take Deposition of TopoTarget UK LTD on 4/10/2020 filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
Filing 60 NOTICE to Take Deposition of Acrotech Biopharma LLC on 4/7/2020 filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
Filing 59 NOTICE of Subpoenas to Beverly W. Lubit by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Farnan, Brian) |
Minute Entry for proceedings held before Judge Colm F. Connolly - Markman Hearing held on 3/4/2020, Discovery Conference held on 3/4/2020. (Court Reporter V. Gunning.) (nmf) |
Filing 58 NOTICE of Appearance by Brian R. Lemon on behalf of Acrotech Biopharma, LLC, TopoTarget UK Ltd. (Lemon, Brian) |
Filing 57 Letter to The Honorable Colm F. Connolly from Daniel M. Silver, Esq. regarding Discovery Dispute - re #56 Letter,. (Silver, Daniel) |
Filing 56 [SEALED] Letter to The Honorable Colm F. Connolly from Brian E. Farnan regarding Discovery Dispute. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Text of Proposed Order, #8 Certification of Counsel)(Farnan, Brian) |
|
Pro Hac Vice Attorney Gregory J. Manas for Acrotech Biopharma, LLC and TopoTarget UK Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
Filing 55 MOTION for Pro Hac Vice Appearance of Attorney Gregory J. Manas - filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd.. (Attachments: #1 Gregory J. Manas)(Silver, Daniel) |
Set Hearings: A Discovery Conference will be held directly following the Markman Hearing on 3/4/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly per request of counsel. (nmf) |
Filing 54 MOTION for Pro Hac Vice Appearance of Attorney Ahmed M.T. Riaz - filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC. (Farnan, Brian) |
|
Filing 53 STIPULATION to Amend Scheduling Order by Acrotech Biopharma, LLC, TopoTarget UK Ltd.. (Silver, Daniel) |
|
Filing 52 EXHIBIT re #43 Claim Construction Chart 027 by Acrotech Biopharma, LLC, TopoTarget UK Ltd.. (Attachments: #1 501)(Silver, Daniel) |
Remark re: D.I. #43 and D.I. #44 The Court's form patent case scheduling orders require the parties to submit with the Joint Claim Construction Chart separate text-searchable pdfs for each asserted patent(s). Parties shall file the separate pdfs electronically using CM/ECF. Each separate pdf shall be labeled using the last three digits of the number of the patent in question so that it is possible to determine from looking at the docket sheet the patent in a particular exhibit. Please comply with this requirement by filing the separate text searchable patents with the proper label as an exhibit to the #43 Claim Construction Chart. (nmf) |
Filing 51 Joint APPENDIX re #50 Claim Construction Opening Brief by Acrotech Biopharma, LLC, Spectrum Pharmaceuticals, Inc., TopoTarget UK Ltd.. (Attachments: #1 Tabs 1 - 11)(Silver, Daniel) |
Filing 50 Joint CLAIM CONSTRUCTION OPENING BRIEF filed by Acrotech Biopharma, LLC, Spectrum Pharmaceuticals, Inc., TopoTarget UK Ltd.. (Silver, Daniel) |
Filing 49 NOTICE of Service of Plaintiffs' Reply Claim Construction Brief by Acrotech Biopharma, LLC, TopoTarget UK Ltd. (Silver, Daniel) |
Filing 48 NOTICE OF SERVICE of Fresenius' Responses and Objections to Plaintiffs' First Set of Interrogatories to Defendants (Nos. 1-5) filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
Filing 47 NOTICE OF SERVICE of (1) Plaintiffs Responses and Objections to Defendants First Set of Interrogatories (Nos. 1-8) and (2) Plaintiffs Opening Claim Construction Brief filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd..(Silver, Daniel) |
|
Pro Hac Vice Attorney Becky E. Steephenson for Acrotech Biopharma, LLC and TopoTarget UK Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
Filing 46 NOTICE OF SERVICE of Plaintiffs First Set of Interrogatories filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd..(Silver, Daniel) |
Filing 45 MOTION for Pro Hac Vice Appearance of Attorney Becky E. Steephenson - filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd.. (Attachments: #1 Becky E. Steephenson Certification)(Silver, Daniel) |
Filing 44 Joint APPENDIX re #43 Claim Construction Chart by Acrotech Biopharma, LLC, TopoTarget UK Ltd.. (Silver, Daniel) |
Filing 43 CLAIM Construction Chart by Acrotech Biopharma, LLC, TopoTarget UK Ltd.. (Silver, Daniel) |
Filing 42 NOTICE OF SERVICE of Plaintiffs Responses and Objections to Defendants First Set of Requests for Production (Nos. 1-34) filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd..(Silver, Daniel) |
Filing 41 NOTICE OF SERVICE of Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Ltd.'s Objections and Responses to Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-27) filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
Filing 40 NOTICE OF SERVICE of Proposed Claim Terms for Construction filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
Filing 39 NOTICE OF SERVICE of Plaintiffs Claim Term Identification filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd..(Silver, Daniel) |
Pro Hac Vice Attorneys William E. Solander and James R. Tyminski for Acrotech Biopharma, LLC and TopoTarget UK Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
Pro Hac Vice Attorney William E. Solander for TopoTarget UK Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
Filing 38 NOTICE OF SERVICE of (i) Fresenius Kabi's First Set of Interrogatories to Plaintiffs (Nos. 1-8) and (ii) Fresenius Kabi's First Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 1-34) filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
Filing 37 NOTICE OF SERVICE of Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-27) to Defendants Fresenius Kabi USA, LLC and Fresenius Kabi Oncology Ltd. filed by Acrotech Biopharma, LLC, TopoTarget UK Ltd..(Silver, Daniel) |
Filing 36 NOTICE requesting Clerk to remove Kathryn E. Easterling as co-counsel.. (Silver, Daniel) |
|
Filing 34 MOTION to Substitute Party: Acrotech Biopharma, LLC to replace Spectrum Pharmaceuticals, Inc. - filed by Spectrum Pharmaceuticals, Inc., TopoTarget UK Ltd.. (Attachments: #1 Text of Proposed Order)(Silver, Daniel) |
Filing 33 NOTICE OF SUBSTITUTION OF COUNSEL re All Plaintiffs : Entry of appearance of attorney Daniel M. Silver. Attorney Jack B. Blumenfeld and Jeffrey J. Lyons terminated. (Silver, Daniel) |
Pro Hac Vice Attorney John K. Hsu for Fresenius Kabi Oncology Ltd.,for Fresenius Kabi USA, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
Filing 32 NOTICE requesting Clerk to remove Stephen J. Smith as co-counsel.. (Farnan, Brian) |
|
Filing 31 MOTION for Pro Hac Vice Appearance of Attorney John K. Hsu - filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC. (Farnan, Brian) |
Filing 30 NOTICE OF SERVICE of Fresenius Kabi's Initial Invalidity Contentions filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
Filing 29 NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by Spectrum Pharmaceuticals, Inc., TopoTarget UK Ltd..(Blumenfeld, Jack) |
Filing 28 MOTION for Pro Hac Vice Appearance of Attorney William E. Solander, James R. Tyminski, and Kathryn E. Easterling - filed by Spectrum Pharmaceuticals, Inc., TopoTarget UK Ltd.. (Lyons, Jeffrey) |
|
Filing 27 NOTICE OF SERVICE of Core Technical Documents filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Michael) |
Filing 26 NOTICE OF SERVICE of Plaintiffs' Disclosures Pursuant to Delaware Default Standard Paragraph 4(a) filed by Spectrum Pharmaceuticals, Inc., TopoTarget UK Ltd..(Lyons, Jeffrey) |
|
Filing 24 NOTICE OF SERVICE of (1) Plaintiffs' Rule 26(a)(1) Initial Disclosures and (2) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information filed by Spectrum Pharmaceuticals, Inc., TopoTarget UK Ltd..(Lyons, Jeffrey) |
Filing 23 NOTICE OF SERVICE of (i) Fresenius Kabi's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and (ii) Fresenius Kabi's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC.(Farnan, Brian) |
Filing 22 Joint PROPOSED ORDER Stipulated Protective Order by Spectrum Pharmaceuticals, Inc., TopoTarget UK Ltd.. (Lyons, Jeffrey) |
|
Pro Hac Vice Attorney Helen H. Ji and Stephen J. Smith for Fresenius Kabi USA, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
|
Set/Reset Hearings: The Final Pretrial Conference is set for 1/28/2021 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly. (nmf) |
CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak) |
|
Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 12/7/2018. (Court Reporter V. Gunning.) (nmf) |
Filing 18 PROPOSED ORDER -- Scheduling Order -- by Spectrum Pharmaceuticals, Inc., TopoTarget UK Ltd.. (Attachments: #1 Letter to the Honorable Colm F. Connolly)(Blumenfeld, Jack) |
Reset Hearings: A Telephonic Scheduling Conference is set for 12/7/2018 at 11:30 AM before Judge Colm F. Connolly. The previous date of 12/5/2018 is cancelled as the court is closed for the National Day of Mourning. (nmf) |
Filing 17 ANSWER to #14 Answer to Complaint, Counterclaim by Spectrum Pharmaceuticals, Inc., TopoTarget UK Ltd..(Blumenfeld, Jack) |
|
Pro Hac Vice Attorney Aly T. Imron for Fresenius Kabi USA, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
Filing 15 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Fresenius Kabi Pharmaceuticals Holding, LLC, Other Affiliate Fresenius Kabi AG, Other Affiliate Fresenius SE & Co. KGaA for Fresenius Kabi USA, LLC; Corporate Parent Fresenius Kabi (Singapore) Pte. Ltd., Other Affiliate Fresenius Kabi AG, Other Affiliate Fresenius SE & Co. KGaA, Other Affiliate Fresenius Kabi Austria GmbH, Other Affiliate Fresenius Kabi Asiaco GmbH, Other Affiliate resenius Kabi Deutschland GmbH for Fresenius Kabi Oncology Ltd. filed by Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, LLC. (Farnan, Brian) |
Filing 14 ANSWER to #1 Complaint, , COUNTERCLAIM against Spectrum Pharmaceuticals, Inc., TopoTarget UK Ltd. by Fresenius Kabi USA, LLC, Fresenius Kabi Oncology Ltd..(Farnan, Brian) |
|
|
Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Imron T. Aly, Stephen J. Smith, and Helen H. Ji - filed by Fresenius Kabi USA, LLC. (Farnan, Brian) |
Filing 11 STIPULATION of Dismissal without prejudice Defendant Fresenius Kabi USA, Inc., and Amending Caption by Spectrum Pharmaceuticals, Inc., TopoTarget UK Ltd.. (Lyons, Jeffrey) |
Filing 10 NOTICE of Change of Law Firm Name and Email Address of Pro Hac Vice Counsel by Spectrum Pharmaceuticals, Inc., TopoTarget UK Ltd. (Lyons, Jeffrey) |
Filing 9 STIPULATION TO EXTEND TIME for Fresenius Kabi USA, LLC and Fresenius Kabi USA, Inc. to move, answer, or otherwise respond to the Complaint to 11/9/2018 - filed by Fresenius Kabi USA, Inc., Fresenius Kabi USA, LLC. (Farnan, Brian) |
|
Filing 8 WAIVER OF SERVICE returned executed by TopoTarget UK Ltd., Spectrum Pharmaceuticals, Inc.: For Fresenius Kabi Oncology Ltd. waiver sent on 10/10/2018, answer due 1/8/2019. (Lyons, Jeffrey) |
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
Filing 7 SUMMONS Returned Executed by TopoTarget UK Ltd., Spectrum Pharmaceuticals, Inc.. Fresenius Kabi USA, LLC served on 10/5/2018, answer due 10/26/2018. (Blumenfeld, Jack) |
Filing 6 SUMMONS Returned Executed by TopoTarget UK Ltd., Spectrum Pharmaceuticals, Inc.. Fresenius Kabi USA, Inc. served on 10/5/2018, answer due 10/26/2018. (Blumenfeld, Jack) |
Summons Issued with Magistrate Consent Notice attached as to Fresenius Kabi Oncology Ltd. on 10/4/2018; Fresenius Kabi USA, Inc. on 10/4/2018; Fresenius Kabi USA, LLC on 10/4/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Onxeo S.A. for TopoTarget UK Ltd. filed by Spectrum Pharmaceuticals, Inc., TopoTarget UK Ltd. (nmg) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) U.S. 6,888,027 ;U.S. 8,835,501. (nmg) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/22/2018. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 1/3/2022. (nmg) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against Fresenius Kabi Oncology Ltd., Fresenius Kabi USA, Inc., Fresenius Kabi USA, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2473508.) - filed by TopoTarget UK Ltd., Spectrum Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet)(nmg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.